Pfizer Loses Lipitor Dispute In Canadian Court
Pfizer Inc. is vowing to appeal after Canada's Federal Court rejected Pfizer Canada's bid to block generics maker Apotex Inc. from marketing a copycat version of the blockbuster cholesterol drug Lipitor...To view the full article, register now.
Already a subscriber? Click here to view full article